Filter Results :

Your search for Virus returned 255 reports

Sort by


Global Human Papilloma Virus Partnering 2010 to 2016

01 May 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry secto...

$ 1,495.00

Read More

Respiratory Syncytial Virus Infections- Market Insights, Epidemiology and Market Forecast-2020

01 May 2016  |  Published by:  DelveInsight
The Respiratory Syncytial Virus Infections- Market Insights, Epidemiology and Market Forecast-2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and middle east countries ...

$ 4,950.00

Read More

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016

20 Apr 2016  |  Published by:  GlobalData
Summary“Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016" provides an overview of Cytomegalovirus (HHV-5) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections. Report includes an overvi...

$ 2,500.00

Read More

West Nile Virus Infections - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘West Nile Virus Infections - Pipeline Review, H1 2016’, provides an overview of the West Nile Virus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for West Nile Virus Infections, complete with analysis by stage of developmen...

$ 2,000.00

Read More

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

04 Apr 2016  |  Published by:  MarketsandMarkets
The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes b...

$ 4,650.00

Read More

Global Respiratory Syncytial Virus Partnering 2010-2016

01 Apr 2016  |  Published by:  CurrentPartnering
Provides understanding and access to the respiratory syncytial virus partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreement...

$ 1,495.00

Read More

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2016’, provides an overview of the Human papillomavirus (HPV) Associated Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development ...

$ 2,000.00

Read More

Poxvirus Infections - Pipeline Review, H1 2016

30 Mar 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Poxvirus Infections - Pipeline Review, H1 2016’, provides an overview of the Poxvirus Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Poxvirus Infections, complete with analysis...

$ 2,000.00

Read More

Coronavirus Infection - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Coronavirus Infection - Pipeline Review, H1 2016’, provides an overview of the Coronavirus Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Coronavirus Infection, complete with analysis by stage of developme...

$ 2,000.00

Read More

Rhinovirus Infection - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Rhinovirus Infection - Pipeline Review, H1 2016’, provides an overview of the Rhinovirus Infection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rhinovirus Infection, complete with analysis by stage of development,...

$ 2,000.00

Read More

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2016

09 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Review, H1 2016’, provides an overview of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection pipeline landscape. The report provides comprehensive information on the therapeutics under d...

$ 2,000.00

Read More

Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines

01 Feb 2016  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence Report „Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines“ provides a competitor evaluation in the field of vaccines on the market or in research & development for prevent...

$ 335.47

Read More

Competitor Analysis: Dengue Virus Vaccines, Antibodies & Antivirals

01 Feb 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report provides a competitor evaluation in the field of approved and investigational vaccines and therapeutics against one or more serotypes of Dengue Virus for prophylaxis or treatment of Dengue fever as of February 2016. The report covers live attenuated or whol...

$ 223.65

Read More

Hepatitis B Virus (HBV) Therapeutics - Current and Future Players

15 Jan 2016  |  Published by:  GlobalData
Summary“Hepatitis B Virus (HBV) Therapeutics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market...

$ 2,995.00

Read More

Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024

15 Jan 2016  |  Published by:  GlobalData
SummaryChronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 millio...

$ 4,995.00

Read More
Total 255 records.